Glucocorticoids and prostate cancer treatment: friend or foe?
Glucocorticoids have been used in the treatment of prostate cancer to slow disease progression, improve pain control and offset side effects of chemo- and hormonal therapy. However, they may also have the potential to drive prostate cancer growth via mutated androgen receptors or glucocorticoid rece...
Main Authors: | Bruce Montgomery, Heather H Cheng, James Drechsler, Elahe A Mostaghel |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2014-06-01
|
Series: | Asian Journal of Andrology |
Subjects: | |
Online Access: | http://www.ajandrology.com/article.asp?issn=1008-682X;year=2014;volume=16;issue=3;spage=354;epage=358;aulast=Montgomery |
Similar Items
-
The Role of Nuclear Receptors in Prostate Cancer
by: Masaki Shiota, et al.
Published: (2019-06-01) -
Aberrant corticosteroid metabolism in tumor cells enables GR takeover in enzalutamide resistant prostate cancer
by: Jianneng Li, et al.
Published: (2017-02-01) -
Mitochondrial Glucocorticoid Receptors and Their Actions
by: Ioanna Kokkinopoulou, et al.
Published: (2021-06-01) -
The Role of Glucocorticoid Receptor Signaling in Bladder Cancer Progression
by: Hiroki Ide, et al.
Published: (2018-12-01) -
Glucocorticoids induce osteoporosis mediated by glucocorticoid receptor-dependent and -independent pathways
by: Yu Jiang, et al.
Published: (2020-05-01)